APO Research
Talk to an analyst

APO RESEARCH · REPORT

Capillary Sequencing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Capillary Sequencing Market Outlook and Growth Opportunities 2026

29 December 2025203 pages

Choose your research edition.

Industry ResearchCapillary Sequencing Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Capillary Sequencing Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Capillary Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Capillary Sequencing Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Capillary Sequencing Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Capillary Sequencing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Capillary Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Capillary Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Capillary Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Capillary Sequencing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Capillary Sequencing market include CRAG, Eurofins Scientific, GENEWIZ, Genomics & Bioinformatics Core Facility (GBCF), GenScript Biotech, Guangzhou Life Technologies DaAn, Hokkaido System Science, LGC Biosearch Technologies and Macrogen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Capillary Sequencing market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Capillary Sequencing and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Capillary Sequencing sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Capillary Sequencing market size, projected growth trends, production technologies, key applications, and end-use industries.

Capillary Sequencing Segment by Company

CRAG

Eurofins Scientific

GENEWIZ

Genomics & Bioinformatics Core Facility (GBCF)

GenScript Biotech

Guangzhou Life Technologies DaAn

Hokkaido System Science

LGC Biosearch Technologies

Macrogen

Molecular Cloning Laboratories (MCLAB)

Psomagen

Thermo Fisher Scientific

Universitat Pompeu Fabra (UPF)

Guangzhou IGE Biotechnology

Tsingke Biotechnology

Shanghai Personalbio Technology

Capillary Sequencing Segment by Type

Based on Fluorescent Labeling

Based on Radioactive Labeling

Capillary Sequencing Segment by Application

Clinical Diagnostics

Forensic Science

Others

Capillary Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Capillary Sequencing status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Capillary Sequencing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Capillary Sequencing significant trends, drivers, influence factors in global and regions.

6. To analyze Capillary Sequencing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Capillary Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Capillary Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Capillary Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Capillary Sequencing market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Capillary Sequencing industry.

Chapter 3: Detailed analysis of Capillary Sequencing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Capillary Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Capillary Sequencing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Capillary Sequencing Industry Trends Table 2. Capillary Sequencing Industry Drivers Table 3. Capillary Sequencing Industry Opportunities and Challenges Table 4. Capillary Sequencing Industry Restraints Table 5. Global Capillary Sequencing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Capillary Sequencing Revenue Share by Company (2021-2026) Table 7. Global Capillary Sequencing Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Capillary Sequencing Sales Volume Share by Company (2021-2026) Table 9. Global Capillary Sequencing Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Capillary Sequencing Company Ranking, (2024-2026) & (USD Million) Table 11. Global Capillary Sequencing Key Company Manufacturing Base & Headquarters Table 12. Global Capillary Sequencing Company, Product Type & Application Table 13. Global Capillary Sequencing Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Capillary Sequencing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Based on Fluorescent Labeling Table 18. Significant Companies of Based on Radioactive Labeling Table 19. Global Capillary Sequencing Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Capillary Sequencing Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Capillary Sequencing Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Capillary Sequencing Sales Volume Share by Type (2021-2026) Table 23. Global Capillary Sequencing Sales Volume Share by Type (2027-2032) Table 24. Global Capillary Sequencing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Capillary Sequencing Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Capillary Sequencing Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Capillary Sequencing Sales Value Share by Type (2021-2026) Table 28. Global Capillary Sequencing Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Clinical Diagnostics Table 30. Significant Companies of Forensic Science Table 31. Significant Companies of Others Table 32. Global Capillary Sequencing Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Capillary Sequencing Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Capillary Sequencing Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Capillary Sequencing Sales Volume Share by Application (2021-2026) Table 36. Global Capillary Sequencing Sales Volume Share by Application (2027-2032) Table 37. Global Capillary Sequencing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Capillary Sequencing Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Capillary Sequencing Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Capillary Sequencing Sales Value Share by Application (2021-2026) Table 41. Global Capillary Sequencing Sales Value Share by Application (2027-2032) Table 42. Global Capillary Sequencing Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Capillary Sequencing Sales by Region (2021-2026) & (K Units) Table 44. Global Capillary Sequencing Sales Market Share by Region (2021-2026) Table 45. Global Capillary Sequencing Sales by Region (2027-2032) & (K Units) Table 46. Global Capillary Sequencing Sales Market Share by Region (2027-2032) Table 47. Global Capillary Sequencing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Capillary Sequencing Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Capillary Sequencing Sales Value Share by Region (2021-2026) Table 50. Global Capillary Sequencing Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Capillary Sequencing Sales Value Share by Region (2027-2032) Table 52. Global Capillary Sequencing Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Capillary Sequencing Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Capillary Sequencing Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Capillary Sequencing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Capillary Sequencing Sales by Country (2021-2026) & (K Units) Table 57. Global Capillary Sequencing Sales Market Share by Country (2021-2026) Table 58. Global Capillary Sequencing Sales by Country (2027-2032) & (K Units) Table 59. Global Capillary Sequencing Sales Market Share by Country (2027-2032) Table 60. Global Capillary Sequencing Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Capillary Sequencing Sales Value Market Share by Country (2021-2026) Table 62. Global Capillary Sequencing Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Capillary Sequencing Sales Value Market Share by Country (2027-2032) Table 64. CRAG Company Information Table 65. CRAG Business Overview Table 66. CRAG Capillary Sequencing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. CRAG Capillary Sequencing Product Portfolio Table 68. CRAG Recent Development Table 69. Eurofins Scientific Company Information Table 70. Eurofins Scientific Business Overview Table 71. Eurofins Scientific Capillary Sequencing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Eurofins Scientific Capillary Sequencing Product Portfolio Table 73. Eurofins Scientific Recent Development Table 74. GENEWIZ Company Information Table 75. GENEWIZ Business Overview Table 76. GENEWIZ Capillary Sequencing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. GENEWIZ Capillary Sequencing Product Portfolio Table 78. GENEWIZ Recent Development Table 79. Genomics & Bioinformatics Core Facility (GBCF) Company Information Table 80. Genomics & Bioinformatics Core Facility (GBCF) Business Overview Table 81. Genomics & Bioinformatics Core Facility (GBCF) Capillary Sequencing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Genomics & Bioinformatics Core Facility (GBCF) Capillary Sequencing Product Portfolio Table 83. Genomics & Bioinformatics Core Facility (GBCF) Recent Development Table 84. GenScript Biotech Company Information Table 85. GenScript Biotech Business Overview Table 86. GenScript Biotech Capillary Sequencing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. GenScript Biotech Capillary Sequencing Product Portfolio Table 88. GenScript Biotech Recent Development Table 89. Guangzhou Life Technologies DaAn Company Information Table 90. Guangzhou Life Technologies DaAn Business Overview Table 91. Guangzhou Life Technologies DaAn Capillary Sequencing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Guangzhou Life Technologies DaAn Capillary Sequencing Product Portfolio Table 93. Guangzhou Life Technologies DaAn Recent Development Table 94. Hokkaido System Science Company Information Table 95. Hokkaido System Science Business Overview Table 96. Hokkaido System Science Capillary Sequencing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Hokkaido System Science Capillary Sequencing Product Portfolio Table 98. Hokkaido System Science Recent Development Table 99. LGC Biosearch Technologies Company Information Table 100. LGC Biosearch Technologies Business Overview Table 101. LGC Biosearch Technologies Capillary Sequencing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. LGC Biosearch Technologies Capillary Sequencing Product Portfolio Table 103. LGC Biosearch Technologies Recent Development Table 104. Macrogen Company Information Table 105. Macrogen Business Overview Table 106. Macrogen Capillary Sequencing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Macrogen Capillary Sequencing Product Portfolio Table 108. Macrogen Recent Development Table 109. Molecular Cloning Laboratories (MCLAB) Company Information Table 110. Molecular Cloning Laboratories (MCLAB) Business Overview Table 111. Molecular Cloning Laboratories (MCLAB) Capillary Sequencing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Molecular Cloning Laboratories (MCLAB) Capillary Sequencing Product Portfolio Table 113. Molecular Cloning Laboratories (MCLAB) Recent Development Table 114. Psomagen Company Information Table 115. Psomagen Business Overview Table 116. Psomagen Capillary Sequencing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Psomagen Capillary Sequencing Product Portfolio Table 118. Psomagen Recent Development Table 119. Thermo Fisher Scientific Company Information Table 120. Thermo Fisher Scientific Business Overview Table 121. Thermo Fisher Scientific Capillary Sequencing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Thermo Fisher Scientific Capillary Sequencing Product Portfolio Table 123. Thermo Fisher Scientific Recent Development Table 124. Universitat Pompeu Fabra (UPF) Company Information Table 125. Universitat Pompeu Fabra (UPF) Business Overview Table 126. Universitat Pompeu Fabra (UPF) Capillary Sequencing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Universitat Pompeu Fabra (UPF) Capillary Sequencing Product Portfolio Table 128. Universitat Pompeu Fabra (UPF) Recent Development Table 129. Guangzhou IGE Biotechnology Company Information Table 130. Guangzhou IGE Biotechnology Business Overview Table 131. Guangzhou IGE Biotechnology Capillary Sequencing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Guangzhou IGE Biotechnology Capillary Sequencing Product Portfolio Table 133. Guangzhou IGE Biotechnology Recent Development Table 134. Tsingke Biotechnology Company Information Table 135. Tsingke Biotechnology Business Overview Table 136. Tsingke Biotechnology Capillary Sequencing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Tsingke Biotechnology Capillary Sequencing Product Portfolio Table 138. Tsingke Biotechnology Recent Development Table 139. Shanghai Personalbio Technology Company Information Table 140. Shanghai Personalbio Technology Business Overview Table 141. Shanghai Personalbio Technology Capillary Sequencing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Shanghai Personalbio Technology Capillary Sequencing Product Portfolio Table 143. Shanghai Personalbio Technology Recent Development Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Capillary Sequencing Distributors List Table 147. Capillary Sequencing Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Capillary Sequencing Product Image Figure 2. Global Capillary Sequencing Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Capillary Sequencing Sales Value (2021-2032) & (US$ Million) Figure 4. Global Capillary Sequencing Sales (2021-2032) & (K Units) Figure 5. Global Capillary Sequencing Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Capillary Sequencing Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Based on Fluorescent Labeling Image Figure 10. Based on Radioactive Labeling Image Figure 11. Global Capillary Sequencing Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Capillary Sequencing Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Capillary Sequencing Sales Volume Share by Type (2021-2032) Figure 14. Global Capillary Sequencing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Capillary Sequencing Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Capillary Sequencing Sales Value Share by Type (2021-2032) Figure 17. Clinical Diagnostics Image Figure 18. Forensic Science Image Figure 19. Others Image Figure 20. Global Capillary Sequencing Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Capillary Sequencing Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Capillary Sequencing Sales Volume Share by Application (2021-2032) Figure 23. Global Capillary Sequencing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Capillary Sequencing Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Capillary Sequencing Sales Value Share by Application (2021-2032) Figure 26. Global Capillary Sequencing Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Capillary Sequencing Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Capillary Sequencing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Capillary Sequencing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Capillary Sequencing Sales Value (2021-2032) & (US$ Million) Figure 31. North America Capillary Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Capillary Sequencing Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Capillary Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Capillary Sequencing Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Capillary Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Capillary Sequencing Sales Value (2021-2032) & (US$ Million) Figure 37. South America Capillary Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Capillary Sequencing Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Capillary Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Capillary Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Capillary Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Capillary Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Capillary Sequencing Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Capillary Sequencing Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Based on Fluorescent Labeling
  • Based on Radioactive Labeling
Applications
  • Clinical Diagnostics
  • Forensic Science
  • Others
Companies covered
  • CRAG
  • Eurofins Scientific
  • GENEWIZ
  • Genomics & Bioinformatics Core Facility (GBCF)
  • GenScript Biotech
  • Guangzhou Life Technologies DaAn
  • Hokkaido System Science
  • LGC Biosearch Technologies
  • Macrogen
  • Molecular Cloning Laboratories (MCLAB)
  • Psomagen
  • Thermo Fisher Scientific
  • Universitat Pompeu Fabra (UPF)
  • Guangzhou IGE Biotechnology
  • Tsingke Biotechnology
  • Shanghai Personalbio Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Capillary Sequencing Sales Value (2021-2032)
  4. 1.2.2 Global Capillary Sequencing Sales Volume (2021-2032)
  5. 1.2.3 Global Capillary Sequencing Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Capillary Sequencing Market Dynamics
  1. 2.1 Capillary Sequencing Industry Trends
  2. 2.2 Capillary Sequencing Industry Drivers
  3. 2.3 Capillary Sequencing Industry Opportunities and Challenges
  4. 2.4 Capillary Sequencing Industry Restraints
3 Capillary Sequencing Market by Company
  1. 3.1 Global Capillary Sequencing Company Revenue Ranking in 2025
  2. 3.2 Global Capillary Sequencing Revenue by Company (2021-2026)
  3. 3.3 Global Capillary Sequencing Sales Volume by Company (2021-2026)
  4. 3.4 Global Capillary Sequencing Average Price by Company (2021-2026)
  5. 3.5 Global Capillary Sequencing Company Ranking (2024-2026)
  6. 3.6 Global Capillary Sequencing Company Manufacturing Base and Headquarters
  7. 3.7 Global Capillary Sequencing Company Product Type and Application
  8. 3.8 Global Capillary Sequencing Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Capillary Sequencing Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Capillary Sequencing Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Capillary Sequencing Market by Type
  1. 4.1 Capillary Sequencing Type Introduction
  2. 4.1.1 Based on Fluorescent Labeling
  3. 4.1.2 Based on Radioactive Labeling
  4. 4.2 Global Capillary Sequencing Sales Volume by Type
  5. 4.2.1 Global Capillary Sequencing Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Capillary Sequencing Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Capillary Sequencing Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Capillary Sequencing Sales Value by Type
  9. 4.3.1 Global Capillary Sequencing Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Capillary Sequencing Sales Value by Type (2021-2032)
  11. 4.3.3 Global Capillary Sequencing Sales Value Share by Type (2021-2032)
5 Capillary Sequencing Market by Application
  1. 5.1 Capillary Sequencing Application Introduction
  2. 5.1.1 Clinical Diagnostics
  3. 5.1.2 Forensic Science
  4. 5.1.3 Others
  5. 5.2 Global Capillary Sequencing Sales Volume by Application
  6. 5.2.1 Global Capillary Sequencing Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Capillary Sequencing Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Capillary Sequencing Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Capillary Sequencing Sales Value by Application
  10. 5.3.1 Global Capillary Sequencing Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Capillary Sequencing Sales Value by Application (2021-2032)
  12. 5.3.3 Global Capillary Sequencing Sales Value Share by Application (2021-2032)
6 Capillary Sequencing Regional Sales and Value Analysis
  1. 6.1 Global Capillary Sequencing Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Capillary Sequencing Sales by Region (2021-2032)
  3. 6.2.1 Global Capillary Sequencing Sales by Region: 2021-2026
  4. 6.2.2 Global Capillary Sequencing Sales by Region (2027-2032)
  5. 6.3 Global Capillary Sequencing Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Capillary Sequencing Sales Value by Region (2021-2032)
  7. 6.4.1 Global Capillary Sequencing Sales Value by Region: 2021-2026
  8. 6.4.2 Global Capillary Sequencing Sales Value by Region (2027-2032)
  9. 6.5 Global Capillary Sequencing Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Capillary Sequencing Sales Value (2021-2032)
  12. 6.6.2 North America Capillary Sequencing Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Capillary Sequencing Sales Value (2021-2032)
  15. 6.7.2 Europe Capillary Sequencing Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Capillary Sequencing Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Capillary Sequencing Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Capillary Sequencing Sales Value (2021-2032)
  21. 6.9.2 South America Capillary Sequencing Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Capillary Sequencing Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Capillary Sequencing Sales Value Share by Country, 2025 VS 2032
7 Capillary Sequencing Country-level Sales and Value Analysis
  1. 7.1 Global Capillary Sequencing Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Capillary Sequencing Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Capillary Sequencing Sales by Country (2021-2032)
  4. 7.3.1 Global Capillary Sequencing Sales by Country (2021-2026)
  5. 7.3.2 Global Capillary Sequencing Sales by Country (2027-2032)
  6. 7.4 Global Capillary Sequencing Sales Value by Country (2021-2032)
  7. 7.4.1 Global Capillary Sequencing Sales Value by Country (2021-2026)
  8. 7.4.2 Global Capillary Sequencing Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Capillary Sequencing Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Capillary Sequencing Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Capillary Sequencing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Capillary Sequencing Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Capillary Sequencing Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Capillary Sequencing Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Capillary Sequencing Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Capillary Sequencing Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Capillary Sequencing Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Capillary Sequencing Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Capillary Sequencing Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Capillary Sequencing Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Capillary Sequencing Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Capillary Sequencing Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Capillary Sequencing Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Capillary Sequencing Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Capillary Sequencing Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Capillary Sequencing Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Capillary Sequencing Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Capillary Sequencing Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Capillary Sequencing Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Capillary Sequencing Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Capillary Sequencing Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Capillary Sequencing Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Capillary Sequencing Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Capillary Sequencing Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Capillary Sequencing Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Capillary Sequencing Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Capillary Sequencing Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Capillary Sequencing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CRAG
  2. 8.1.1 CRAG Company Information
  3. 8.1.2 CRAG Business Overview
  4. 8.1.3 CRAG Capillary Sequencing Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CRAG Capillary Sequencing Product Portfolio
  6. 8.1.5 CRAG Recent Developments
  7. 8.2 Eurofins Scientific
  8. 8.2.1 Eurofins Scientific Company Information
  9. 8.2.2 Eurofins Scientific Business Overview
  10. 8.2.3 Eurofins Scientific Capillary Sequencing Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Eurofins Scientific Capillary Sequencing Product Portfolio
  12. 8.2.5 Eurofins Scientific Recent Developments
  13. 8.3 GENEWIZ
  14. 8.3.1 GENEWIZ Company Information
  15. 8.3.2 GENEWIZ Business Overview
  16. 8.3.3 GENEWIZ Capillary Sequencing Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GENEWIZ Capillary Sequencing Product Portfolio
  18. 8.3.5 GENEWIZ Recent Developments
  19. 8.4 Genomics & Bioinformatics Core Facility (GBCF)
  20. 8.4.1 Genomics & Bioinformatics Core Facility (GBCF) Company Information
  21. 8.4.2 Genomics & Bioinformatics Core Facility (GBCF) Business Overview
  22. 8.4.3 Genomics & Bioinformatics Core Facility (GBCF) Capillary Sequencing Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Genomics & Bioinformatics Core Facility (GBCF) Capillary Sequencing Product Portfolio
  24. 8.4.5 Genomics & Bioinformatics Core Facility (GBCF) Recent Developments
  25. 8.5 GenScript Biotech
  26. 8.5.1 GenScript Biotech Company Information
  27. 8.5.2 GenScript Biotech Business Overview
  28. 8.5.3 GenScript Biotech Capillary Sequencing Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 GenScript Biotech Capillary Sequencing Product Portfolio
  30. 8.5.5 GenScript Biotech Recent Developments
  31. 8.6 Guangzhou Life Technologies DaAn
  32. 8.6.1 Guangzhou Life Technologies DaAn Company Information
  33. 8.6.2 Guangzhou Life Technologies DaAn Business Overview
  34. 8.6.3 Guangzhou Life Technologies DaAn Capillary Sequencing Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Guangzhou Life Technologies DaAn Capillary Sequencing Product Portfolio
  36. 8.6.5 Guangzhou Life Technologies DaAn Recent Developments
  37. 8.7 Hokkaido System Science
  38. 8.7.1 Hokkaido System Science Company Information
  39. 8.7.2 Hokkaido System Science Business Overview
  40. 8.7.3 Hokkaido System Science Capillary Sequencing Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hokkaido System Science Capillary Sequencing Product Portfolio
  42. 8.7.5 Hokkaido System Science Recent Developments
  43. 8.8 LGC Biosearch Technologies
  44. 8.8.1 LGC Biosearch Technologies Company Information
  45. 8.8.2 LGC Biosearch Technologies Business Overview
  46. 8.8.3 LGC Biosearch Technologies Capillary Sequencing Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 LGC Biosearch Technologies Capillary Sequencing Product Portfolio
  48. 8.8.5 LGC Biosearch Technologies Recent Developments
  49. 8.9 Macrogen
  50. 8.9.1 Macrogen Company Information
  51. 8.9.2 Macrogen Business Overview
  52. 8.9.3 Macrogen Capillary Sequencing Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Macrogen Capillary Sequencing Product Portfolio
  54. 8.9.5 Macrogen Recent Developments
  55. 8.10 Molecular Cloning Laboratories (MCLAB)
  56. 8.10.1 Molecular Cloning Laboratories (MCLAB) Company Information
  57. 8.10.2 Molecular Cloning Laboratories (MCLAB) Business Overview
  58. 8.10.3 Molecular Cloning Laboratories (MCLAB) Capillary Sequencing Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Molecular Cloning Laboratories (MCLAB) Capillary Sequencing Product Portfolio
  60. 8.10.5 Molecular Cloning Laboratories (MCLAB) Recent Developments
  61. 8.11 Psomagen
  62. 8.11.1 Psomagen Company Information
  63. 8.11.2 Psomagen Business Overview
  64. 8.11.3 Psomagen Capillary Sequencing Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Psomagen Capillary Sequencing Product Portfolio
  66. 8.11.5 Psomagen Recent Developments
  67. 8.12 Thermo Fisher Scientific
  68. 8.12.1 Thermo Fisher Scientific Company Information
  69. 8.12.2 Thermo Fisher Scientific Business Overview
  70. 8.12.3 Thermo Fisher Scientific Capillary Sequencing Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Thermo Fisher Scientific Capillary Sequencing Product Portfolio
  72. 8.12.5 Thermo Fisher Scientific Recent Developments
  73. 8.13 Universitat Pompeu Fabra (UPF)
  74. 8.13.1 Universitat Pompeu Fabra (UPF) Company Information
  75. 8.13.2 Universitat Pompeu Fabra (UPF) Business Overview
  76. 8.13.3 Universitat Pompeu Fabra (UPF) Capillary Sequencing Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Universitat Pompeu Fabra (UPF) Capillary Sequencing Product Portfolio
  78. 8.13.5 Universitat Pompeu Fabra (UPF) Recent Developments
  79. 8.14 Guangzhou IGE Biotechnology
  80. 8.14.1 Guangzhou IGE Biotechnology Company Information
  81. 8.14.2 Guangzhou IGE Biotechnology Business Overview
  82. 8.14.3 Guangzhou IGE Biotechnology Capillary Sequencing Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Guangzhou IGE Biotechnology Capillary Sequencing Product Portfolio
  84. 8.14.5 Guangzhou IGE Biotechnology Recent Developments
  85. 8.15 Tsingke Biotechnology
  86. 8.15.1 Tsingke Biotechnology Company Information
  87. 8.15.2 Tsingke Biotechnology Business Overview
  88. 8.15.3 Tsingke Biotechnology Capillary Sequencing Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Tsingke Biotechnology Capillary Sequencing Product Portfolio
  90. 8.15.5 Tsingke Biotechnology Recent Developments
  91. 8.16 Shanghai Personalbio Technology
  92. 8.16.1 Shanghai Personalbio Technology Company Information
  93. 8.16.2 Shanghai Personalbio Technology Business Overview
  94. 8.16.3 Shanghai Personalbio Technology Capillary Sequencing Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Shanghai Personalbio Technology Capillary Sequencing Product Portfolio
  96. 8.16.5 Shanghai Personalbio Technology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Capillary Sequencing Value Chain Analysis
  2. 9.1.1 Capillary Sequencing Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Capillary Sequencing Sales Mode & Process
  6. 9.2 Capillary Sequencing Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Capillary Sequencing Distributors
  9. 9.2.3 Capillary Sequencing Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst